// STATE LEGISLATION TRACKER

Kansas SB 497: Adding kratom to schedule I of the uniform controlled substances act and making conforming amendments to the definition

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Kansas
Bill: SB 497
Session: 2025-2026
Filed: 2026-02-06
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Kansas SB497 targets kratom, not peptides. It would place key kratom compounds into Schedule I and make related fentanyl-definition cleanup changes, with no direct change to compounded peptides, off-label peptide prescribing, telehealth, or clinician scope.

Key Points

No direct change to peptide access or prescribing
No 503A or 503B compounding changes identified
No telehealth rule changes identified
No NP or naturopath scope changes identified
Kratom users would face controlled-substance risk if similar language advances

What to Watch For

Note The Kansas Legislature page now lists SB497 as died, despite earlier introduced-stage summaries.

Concern Similar kratom scheduling language may reappear in another controlled-substances bill.

Note This is controlled-substances policy, but it does not appear to target peptide medicines.

Where the Bill Stands

The official Kansas Legislature page lists SB497 as died after Senate action, so it did not become law as SB497.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws